Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1984; 3:1309-1320
© 1984 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Panidis, I.
Right arrow Articles by Kalman, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Panidis, I.
Right arrow Articles by Kalman, P

Development and regression of left ventricular hypertrophy

IP Panidis, MN Kotler, JF Ren, GS Mintz, J Ross, and P Kalman

Left ventricular hypertrophy is an important adaptive response to chronic pressure or volume overload of the left ventricle. The different types and the pathophysiologic mechanisms of the development of left ventricular hypertrophy in various disease states are reviewed. Detection of left ventricular hypertrophy may be accomplished by electrocardiography and cardiac angiography. Echocardiography, however, is the most accurate noninvasive method to detect the presence and estimate the severity of increased left ventricular mass. The clinical significance of left ventricular hypertrophy and its prognostic implications in several cardiac diseases associated with hypertrophy are discussed. The critical transition stage from adaptive, compensatory and reversible left ventricular hypertrophy to "pathologic" hypertrophy with impaired left ventricular contractility and irreversible myocardial damage is yet unknown. Recent data are presented that provide evidence of regression of left ventricular hypertrophy after medical treatment of patients with hypertension and after aortic valve replacement in patients with aortic valve disease. The clinical importance of regression of hypertrophy and its effects on long-term prognosis remain to be determined.


This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
J. Boissiere, V. Eder, M.-C. Machet, D. Courteix, and P. Bonnet
Moderate exercise training does not worsen left ventricle remodeling and function in untreated severe hypertensive rats
J Appl Physiol, February 1, 2008; 104(2): 321 - 327.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Asaumi, Y. Kagaya, M. Takeda, N. Yamaguchi, H. Tada, K. Ito, J. Ohta, T. Shiroto, K. Shirato, N. Minegishi, et al.
Protective Role of Endogenous Erythropoietin System in Nonhematopoietic Cells Against Pressure Overload-Induced Left Ventricular Dysfunction in Mice
Circulation, April 17, 2007; 115(15): 2022 - 2032.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Eghtesady, E. Michelfelder, M. Altaye, E. Ballard, R. Hirsh, and R. H. Beekman III
Revisiting Animal Models of Aortic Stenosis in the Early Gestation Fetus
Ann. Thorac. Surg., February 1, 2007; 83(2): 631 - 639.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Sharma, I. C. Okere, M. K. Duda, D. J. Chess, K. M. O'Shea, and W. C. Stanley
Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy
Cardiovasc Res, January 15, 2007; 73(2): 257 - 268.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Sakamoto, T. Minamino, H. Toko, Y. Kayama, Y. Zou, M. Sano, E. Takaki, T. Aoyagi, K. Tojo, N. Tajima, et al.
Upregulation of Heat Shock Transcription Factor 1 Plays a Critical Role in Adaptive Cardiac Hypertrophy
Circ. Res., December 8, 2006; 99(12): 1411 - 1418.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. Guenzinger, W. B. Eichinger, F. Botzenhardt, S. Bleiziffer, I. Wagner, R. Bauernschmitt, S. M. Wildhirt, and R. Lange
Rest and Exercise Performance of the Medtronic Advantage Bileaflet Valve in the Aortic Position
Ann. Thorac. Surg., October 1, 2005; 80(4): 1319 - 1326.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X.-M. Gao, H. Kiriazis, X.-L. Moore, X.-H. Feng, K. Sheppard, A. Dart, and X.-J. Du
Regression of pressure overload-induced left ventricular hypertrophy in mice
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2702 - H2707.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Le Bret, J. M. Lupoglazoff, N. Borenstein, G. Fromont, F. Laborde, J. Bachet, and P. Vouhe
Cardiac "Fitness" Training: An Experimental Comparative Study of Three Methods of Pulmonary Artery Banding for Ventricular Training
Ann. Thorac. Surg., January 1, 2005; 79(1): 198 - 203.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Gaudino, F. Alessandrini, F. Glieca, N. Luciani, C. Cellini, C. Pragliola, M. Morelli, C. Canosa, G. Nasso, and G. Possati
Survival after aortic valve replacement for aortic stenosis: does left ventricular mass regression have a clinical correlate?
Eur. Heart J., January 1, 2005; 26(1): 51 - 57.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Iemitsu, T. Miyauchi, S. Maeda, S. Sakai, T. Kobayashi, N. Fujii, H. Miyazaki, M. Matsuda, and I. Yamaguchi
Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R2029 - R2036.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. T. Christakis, C. D. Joyner, C. D. Morgan, S. E. Fremes, K. J. Buth, J. Y. Sever, V. Rao, K. P. Panagiotopoulos, P. M. Murphy, and B. S. Goldman
Left Ventricular Mass Regression Early After Aortic Valve Replacement
Ann. Thorac. Surg., October 1, 1996; 62(4): 1084 - 1089.
[Abstract] [Full Text]


Home page
CirculationHome page
P. R. Liebson, G. A. Grandits, S. Dianzumba, R. J. Prineas, R. H. Grimm Jr, J. D. Neaton, and J. Stamler
Comparison of Five Antihypertensive Monotherapies and Placebo for Change in Left Ventricular Mass in Patients Receiving Nutritional-Hygienic Therapy in the Treatment of Mild Hypertension Study (TOMHS)
Circulation, February 1, 1995; 91(3): 698 - 706.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
D. M. Cummings, P. Amadio Jr, L. Nelson, and J. M. Fitzgerald
The Role of Calcium Channel Blockers in the Treatment of Essential Hypertension
Arch Intern Med, February 1, 1991; 151(2): 250 - 259.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
D. Levy, R. J. Garrison, D. D. Savage, W. B. Kannel, and W. P. Castelli
Left Ventricular Mass and Incidence of Coronary Heart Disease in an Elderly Cohort: The Framingham Heart Study
Ann Intern Med, January 15, 1989; 110(2): 101 - 107.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
D. LEVY, K. M. ANDERSON, D. D. SAVAGE, W. B. KANNEL, J. C. CHRISTIANSEN, and W. P. CASTELLI
Echocardiographically Detected Left Ventricular Hypertrophy: Prevalence and Risk Factors: The Framingham Heart Study
Ann Intern Med, January 1, 1988; 108(1): 7 - 13.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
Drugs Five Years Later: Nifedipine in Myocardial Ischemia, Systemic Hypertension, and Other Cardiovascular Disorders
Ann Intern Med, November 1, 1986; 105(5): 714 - 729.
[Abstract] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement